Simone Steiner leads the technology development and manufacturing teams at Tigen Pharma. Prior to Tigen, she successfully built and headed the Novartis Production Unit / Cell Therapy Facility in Stein, Switzerland, where the pioneering leukemia cell therapy Kymriah was initiated. She also held Cell & Gene leadership roles as a supplier relationship manager and a product Stewart. She started her industrial career at QSV Biologics as a CDMO downstream processing scientist.
Simone holds a diploma in biochemistry and a PhD from the ETH Zurich. She was also a post-doctoral fellow at the University of Alberta, Canada.
Presentation Title: